AbbVie Inc. (NYSE:ABBV)

Pair of dice

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »
refinery

Jefferies Adds Big Dividend-Paying Leader to Franchise Picks List

As we head deeper into February, many of the top firms we cover here at 24/7 Wall St. are tweaking their high-conviction stock lists for 2017, and many are trying ...
Read Full Story »
white pills

AbbVie Slides on Mixed Q4 Earnings

When AbbVie Inc. (NYSE: ABBV) reported its fourth-quarter financial results before the markets opened on Friday, it posted $1.20 in earnings per share (EPS) and $6.8 billion in revenue. Consensus ...
Read Full Story »
Prescription drugs

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »
Good heart health

What to Expect From Major Health Care Stocks Reporting This Week

As January comes to a close, we are in the heart of earnings season, when most companies report and set a direction for the market. Dow 20,000 has been reached but ...
Read Full Story »
research

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

While the run since the Trump election and now the inauguration has been solid, there are some storm clouds on the horizon. Volatility has drifted to historic lows, while price-to-earnings ...
Read Full Story »
ThinkstockPhotos-475180302

7 Key Earnings Coming This Week

24/7 Wall St. has put together a preview of some of the major companies scheduled to share their quarterly results in the coming days, as we are in the heart of ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Declines Ahead of Trump Comments

The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Prescription drugs

Short Interest Rises in Major Pharma

The short interest data have been released for the December 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Newell Brands

Jefferies Makes Huge Year-End Addition to Franchise Picks List

As we have reported recently, many of the top firms on Wall Street that we cover at 24/7 Wall St. have made some final tweaks and changes to their top ...
Read Full Story »
Prescription drugs

Short Sellers Back Way Off Major Pharma Stocks

The short interest data have been released for the November 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
buy now

Bond Sell-Off Could Be Huge for Stocks: 4 Analyst Top Pick Dividend Stocks to Buy Now

Despite the recent highs in the market, investor enthusiasm for stocks has been lousy for years, but that could all be changing now. Jefferies reports that, since the 2009 lows ...
Read Full Story »
Prescription drugs

Short Sellers Hike Their Bets in Most Major Pharma Stocks

The short interest data have been released for the November 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
New York Stock Exchange

Jefferies Makes Another Huge Addition to Franchise Picks Stocks Portfolio

With earnings for the third quarter over, and the fourth quarter of 2016 in full swing, many of the top companies we follow on Wall Street are making some ...
Read Full Story »
Prescription drugs

Short Interest Bets Increase on Major Pharma

The short interest data have been released for the October 31 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »